Jane Street’s Lisata Therapeutics LSTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,144
Closed -$9K 10124
2022
Q2
$9K Buy
1,144
+33
+3% +$272 ﹤0.01% 9333
2022
Q1
$12K Sell
1,111
-348
-24% -$3.98K ﹤0.01% 10040
2021
Q4
$18K Buy
+1,459
New +$22.5K ﹤0.01% 9820
2020
Q3
Sell
-719
Closed -$19K 7591
2020
Q2
$19K Buy
+719
New +$21.2K ﹤0.01% 6971
2014
Q3
Sell
-573
Closed -$560K 2850
2014
Q2
$560K Buy
573
+158
+38% +$154K 0.01% 1314
2014
Q1
$439K Buy
+415
New +$450K ﹤0.01% 1690

Other funds holding LSTA

Jane Street's LSTA Position: Q3 2022 in Review

Jane Street sold out of Lisata Therapeutics (LSTA) in Q3 2022, closing a stake of 1,144 shares — an estimated $9K sold.

Jane Street first reported a position in LSTA in Q1 2014 and held it in 6 quarters. The position peaked at $560K in Q2 2014. 22 funds tracked by Wall St. Rank hold LSTA as of Q3 2022.

  • Jane Street reported no remaining Lisata Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Jane Street sold 1,144 Lisata Therapeutics shares in Q3 2022, an estimated $9K.
  • Jane Street first reported a position in Lisata Therapeutics in Q1 2014 and held it in 6 quarters.
  • Jane Street's Lisata Therapeutics position peaked at $560K in Q2 2014.
  • 22 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2022.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.